The flu is on our doorstep, and soon it will be knocking
Each year, science attempts to outpace nature by predicting which influenza strain will dominate months before it arrives — and sometimes, nature moves faster. This winter, Maine health officials are confronting that gap directly, as a variant of the H3N2 flu strain spreading across the Northern Hemisphere does not align precisely with the current season's vaccine. The mismatch is a reminder that public health is an act of informed humility, not certainty — and that imperfect protection, offered widely, remains far better than none at all.
- A globally spreading H3N2 variant has caught scientists off guard, arriving with genetic variations that weren't anticipated when this season's vaccines were formulated months ago.
- The strain carries a troubling track record — H3N2 hits older adults hardest and has repeatedly ignited outbreaks in long-term care facilities, raising the stakes for Maine's most vulnerable populations.
- In the UK, H3N2 cases have tripled, and the WHO has flagged the strain as rapidly predominating across the Northern Hemisphere, signaling that Maine's current count of 90 cases may be only the beginning.
- Health officials are pushing back against vaccine hesitancy born of the mismatch, stressing that a partial match still sharply reduces the risk of hospitalization and severe illness.
- The season remains fluid — H1N1 and Influenza B could yet emerge and shift the landscape entirely, meaning the calculus for getting vaccinated now only grows stronger with time.
The flu vaccine available this season may not be a perfect match for the virus already circulating — and Maine health officials are being candid about that uncomfortable reality while delivering an equally clear message: get vaccinated anyway.
A variant of H3N2, the dominant influenza strain in the Northern Hemisphere, has been spreading through the UK, Canada, Japan, and beyond with a genetic signature that diverges from what manufacturers predicted earlier this year. These late-emerging subclades caught scientists off guard. Dr. Dora Anne Mills of MaineHealth is preparing Mainers for a harder winter than usual, warning that the flu may prove more severe than normal — particularly for older adults, who are most vulnerable to H3N2's potency, and for residents of long-term care facilities where outbreaks can spread quickly.
Maine has recorded 90 confirmed flu cases since October, a modest number compared to nearly 18,000 across the full 2024-25 season — but the season is young. The mismatch itself is a structural reality of flu vaccine production: scientists must predict dominant strains each February, manufacturers spend months producing doses, and by fall, the virus has sometimes shifted. 'Every once in a while we see a shift in the virus that makes the vaccine not a great match,' said Maine CDC epidemiologist Anna Krueger.
Still, imperfect is not the same as ineffective. The vaccine can still prevent the worst outcomes — keeping people out of hospitals even if it doesn't prevent infection entirely. And the season's trajectory remains uncertain; H1N1 and Influenza B could emerge at any point and change which strain dominates. Public health officials are unified: get the shot, combine it with an updated COVID-19 vaccine if possible, and lean on the enduring basics — staying home when sick, washing hands, and practicing respiratory hygiene. For those 50 and older or pregnant, RSV vaccines add another layer of protection against what may be a demanding respiratory season ahead.
The flu vaccine sitting in your doctor's office right now may not be a perfect match for the virus circulating outside. That's the uncomfortable truth Maine health officials are grappling with as the 2025-26 flu season takes shape, and it's prompting a familiar but urgent message: get vaccinated anyway.
A variant of H3N2, the dominant influenza strain in the Northern Hemisphere, has been spreading through the United Kingdom, Canada, Japan, and other countries with a genetic signature that doesn't align precisely with what manufacturers predicted months ago. These small variations, called subclades, emerged late in the Southern Hemisphere's flu season and caught scientists off guard. The concern is real enough that Dr. Dora Anne Mills, chief health improvement officer for MaineHealth, is preparing the public for what could be a rougher winter than usual. "The flu is on our doorstep, and soon it will be knocking on our door," she said. "It may be a more severe season than normal."
The worry centers on H3N2's particular potency, especially among older adults. This strain has a track record of driving hospitalizations and outbreaks in long-term care facilities—places where vulnerability is already high. In the United Kingdom, H3N2 cases have tripled. Dr. Wenqing Zhang, who heads the World Health Organization's Global Respiratory Threats Unit, noted this week that the strain is "rapidly spreading and predominating in some countries so far in the northern hemisphere."
Maine's numbers so far are modest. The state has recorded 90 confirmed flu cases since the season began in October, compared to 17,793 cases during the entire 2024-25 season, which runs through May. But the season is still young. The mismatch between vaccine and virus exists because of a fundamental timing problem: scientists make their best prediction each February about which strains will dominate the following winter. Manufacturers then spend months producing and distributing millions of doses. By the time shots reach arms in the fall, the virus has sometimes shifted. "Every once in a while we see a shift in the virus that makes the vaccine not a great match," said Anna Krueger, an epidemiologist with the Maine CDC.
But here's what matters: an imperfect match is not the same as no match. The vaccine will still provide protection, particularly against the worst outcomes. It may not prevent infection entirely, but it can keep people out of the hospital. And the flu landscape remains unpredictable. Other strains—H1N1, Influenza B—could emerge and take over at any point during the season. "It's too early to tell if any one strain will dominate," Krueger said. "There's no typical flu season, but many times we will see Influenza A in the early season, and Influenza B later."
Public health officials are unified in their advice: get the shot. Vaccination is widely available at doctor's offices and pharmacies. You can get your flu vaccine and the updated COVID-19 vaccine in the same visit. Beyond that, the old wisdom holds: stay home when sick, wash your hands, and pay attention to respiratory hygiene. For those 50 and older, or pregnant people between 32 and 36 weeks, RSV vaccines are also available—another layer of protection against the seasonal respiratory illnesses that will circulate through the winter months ahead.
Citações Notáveis
The flu is on our doorstep, and soon it will be knocking on our door. It may be a more severe season than normal.— Dr. Dora Anne Mills, MaineHealth
Every once in a while we see a shift in the virus that makes the vaccine not a great match.— Anna Krueger, Maine CDC epidemiologist
A Conversa do Hearth Outra perspectiva sobre a história
If the vaccine doesn't match the virus perfectly, why bother getting it at all?
Because a partial match is still a shield. It may not stop you from catching the flu, but it can mean the difference between a bad week at home and a week in the hospital. For older people especially, that matters enormously.
How did scientists get it wrong? Don't they know what's coming?
They make their best guess in February based on what they're seeing globally. But viruses mutate. By the time millions of doses are manufactured and distributed, the virus has sometimes shifted in ways nobody predicted. It's a race against biology.
So this could be a really bad winter?
It could be worse than average, yes. H3N2 is a particularly nasty strain for older adults and people in care facilities. But "could be" is the operative phrase. Other strains might take over. The season is unpredictable.
What should someone actually do?
Get vaccinated. Get it soon. You can do it alongside your COVID booster in one appointment. Then practice the basics—stay home if you're sick, wash your hands. It's not dramatic, but it works.
Is Maine in particular at risk?
Not uniquely. Maine is watching the same virus spreading in the U.K., Canada, and Japan. We're 90 cases in so far this season. The real vulnerability is in long-term care facilities and among older adults, wherever they are.